MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Magnetic resonance imaging(MRI)"

  • 2025 International Congress

    Correlations of plasma glial fibrillary acidic protein levels with glymphatic system impairment in Huntington’s disease

    JH. Yin, LY. Lu, Q. Yang, Y. Huang (Beijing, China)

    Objective: To investigate whether plasma glial fibrillary acidic protein (GFAP) levels are related to glymphatic system function in Huntington's disease (HD). Background: Plasma GFAP levels has…
  • 2025 International Congress

    Longitudinal Brain Morphometric Trajectories Across Parkinson Disease Clinical Subtypes

    A. Eid, S. Grossen, A. Tanenbaum, J. Hood, H. Hwang, T. Cash, C. Lessov-Schlaggar, J. Jackson, P. Kotzbauer, J. Perlmutter, M. Campbell (Saint Louis, USA)

    Objective: To investigate longitudinal brain morphometric trajectories across Parkinson disease (PD) clinical subtypes Background: We developed a PD multi-domain classification based on motor and non-motor…
  • 2025 International Congress

    Clinical And Cerebellar Structural Alterations In Parkinson’s Disease Patients With Freezing Of Gait

    E. Sarasso, A. Gardoni, A. Grassi, L. Zenere, S. Basaia, G. Bonardi, S. Carta, I. Di Vico, E. Mantovani, E. Canu, M. Bressan, V. Castelnovo, E. Sibilla, C. Tripodi, F. Freri, R. Balestrino, M. Trentinaglia, F. Maffei, V. Chiodega, S. Tamburin, MA. Volontè, S. Mariotto, M. Tinazzi, M. Filippi, F. Agosta (Milan, Italy)

    Objective: To assess clinical and cerebellar volume differences in Parkinson’s disease (PD) patients with and without freezing of gait (PD-FoG and PD-NOFoG). Background: Cerebellum plays…
  • 2025 International Congress

    Atrophy In Multiple System Atrophy Relates To Mitochondrial And Oligodendrocytic Processes

    L. Chougar, C. Tremblay, A. Delva, M. Filiatraul, A. Vo, J. Hansen, A. Farahani, B. Misic, P. Khalafi, CE. Castonguay, G. Rouleau, JC. Corvol, M. Vidailhet, B. Degos, D. Grabli, S. Lehéricy, A. Dagher, S. Rahayel (Montreal, Canada)

    Objective: To investigate the gene expression and neurobiological underpinnings of brain atrophy in MSA using imaging transcriptomics and PET-based molecular annotation Background: The biological mechanisms…
  • 2025 International Congress

    Widespread White Matter Changes in Manifest Huntington’s Disease

    S. Zadegan, TM. Cordeiro, E. Furr Stimming, A. Teixeira, N. Rocha (San Antonio, USA)

    Objective: To characterize white matter changes in Huntington’s Disease (HD). Background: HD is a genetic neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms. Diffusion Tensor…
  • 2025 International Congress

    χ-DBS: An Open-Source Susceptibility Atlas Tool for Deep Brain Stimulation Target Visualization and Segmentation

    A. Roberts, J. Avecillas-Chasin, M. Spadaccia, S. Akkus, A. Dimov, M. Sisman, P. Spincemaille, T. Nguyen, B. Kopell, Y. Wang (Ithaca, USA)

    Objective: This work is motivated by the need for atlas creation tools for susceptibility maps presurgically acquired for deep brain stimulation (DBS). Segmentations aid in…
  • 2025 International Congress

    Diffusion MRI Changes Linked to α-Synuclein Seed Amplification Status in Parkinson’s Disease

    S. Chiu, W. Wang, R. Chen, J. Desimone, C. Adler, S. Mehta, S. Dresler, N. Mcfarland, M. Okun, D. Vaillancourt (Scottsdale, USA)

    Objective: To compare free-water (FW) imaging in individuals with Parkinson’s disease (PD), with positive vs. negative cerebrospinal fluid (CSF) α-synuclein seed amplification assay (SAA) status.…
  • 2025 International Congress

    White Matter Abnormalities in Progressive Supranuclear Palsy (PSP) vs. Parkinson’s Disease (PD): Evaluation with a Convolutional Neural Network (CNN)-Based Tool

    S. Zaheer, Y. Patel, M. Abarghouei Emamikhah, N. Bendahan, R. Zou, M. Malik, N. Owsicki, N. Paul, Q. Nguyen Victor, A. Boutet, A. Lang (Toronto, Canada)

    Objective: This study aimed to compare white matter hyperintensity (WMH) burden between PSP and PD using a novel AI-based tool for more accurate WMH volume…
  • 2025 International Congress

    Correlation of 7T MRI Susceptibility and Retinal Nerve Fiber Thickness with Neurological Severity in Wilson’s Disease

    I. Brum, I. Prates, J. Cordeiro, F. Otsuka, R. Guidi, P. Barbosa, R. Cury, M. Otaduy, L. Lucato, E. Barbosa, J. Parmera (Sao Paulo, Brazil)

    Objective: To evaluate susceptibility changes in the lentiform nucleus using 7T MRI and peripapillary retinal nerve fiber layer (p-RNFL) thickness using Optical Coherence Tomography (OCT)…
  • 2025 International Congress

    Brain Energetics: Changes in Healthy Aging and Parkinson’s Disease

    C. Bevington, S. Dhaliwal, J. Mckenzie, A. Stoessl, V. Sossi (Vancouver, Canada)

    Objective: To identify in vivo bioenergetic alterations in healthy aging and Parkinson’s disease (PD). Background: PD-related cerebral metabolic alterations have been robustly characterized [1] and…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 78
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley